HANISH ARNOLD C — SEC Form 4 filings
SEC reporting owner CIK 1233253. 8 Form 4 filings on record with FilingPulse; latest filed 2026-09-02.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-02-22 to 2026-09-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 5,000 shares, $3,740 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 5 legs across 2 filings — 15,027 shares, $282,111 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: sale of 5,000 shares @ $19.02 ($95,081) in OMEROS CORP, filed 2026-08-28.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| OMEROS CORP (OMER) | Director | 4 | — | 3 legs · 15,000 sh · $282,094 | 9 |
| Decoy Therapeutics Inc. (DCOY) | Director | 4 | 1 leg · 5,000 sh · $3,740 | 2 legs · 27 sh · $17 | 2 |
Form 4 filings — HANISH ARNOLD C
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-02 | 4 | Decoy Therapeutics Inc. (DCOY) | Grant/award (A): 3,000 @ $0 | EDGAR |
| 2026-08-28 | 4 | OMEROS CORP (OMER) | Option exercise (M): 5,000 @ $15.81 · Sale (S): 5,000 @ $18.53 · Option exercise (M): 2,500 @ $15.81 · Option exercise (M): 7,500 @ $14.66 · Sale (S): 5,000 @ $18.88 · Sale (S): 5,000 @ $19.02 · +3 more | EDGAR |
| 2026-06-22 | 4 | OMEROS CORP (OMER) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2026-01-02 | 4 | Salarius Pharmaceuticals, Inc. (SLRX) | Sale (S): 15 @ $0.64 · Sale (S): 12 @ $0.64 | EDGAR |
| 2025-11-24 | 4 | Salarius Pharmaceuticals, Inc. (SLRX) | Purchase (P): 5,000 @ $0.75 | EDGAR |
| 2025-07-01 | 4 | OMEROS CORP (OMER) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | OMEROS CORP (OMER) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2024-02-22 | 4 | Salarius Pharmaceuticals, Inc. (SLRX) | Grant/award (A): 20,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1233253 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →